Secondary |
Pain |
15.9% |
Thrombosis Prophylaxis |
15.4% |
Hypertension |
10.7% |
Product Used For Unknown Indication |
9.3% |
Pyrexia |
4.7% |
Arthritis |
4.2% |
Chronic Obstructive Pulmonary Disease |
4.2% |
Nausea |
3.7% |
Cough |
3.3% |
Pruritus |
3.3% |
Cardiomyopathy |
2.8% |
Pneumonia Aspiration |
2.8% |
Prophylaxis |
2.8% |
Supportive Care |
2.8% |
Acute Myocardial Infarction |
2.3% |
Cardiac Failure |
2.3% |
Constipation |
2.3% |
Electrolyte Substitution Therapy |
2.3% |
Fluid Replacement |
2.3% |
Sedation |
2.3% |
|
Toxic Epidermal Necrolysis |
24.3% |
Cerebrovascular Accident |
5.4% |
Erythema |
5.4% |
Haemoglobin Decreased |
5.4% |
Heparin-induced Thrombocytopenia |
5.4% |
Pulmonary Embolism |
5.4% |
Puncture Site Haemorrhage |
5.4% |
Stevens-johnson Syndrome |
5.4% |
Visual Acuity Reduced |
5.4% |
Warm Type Haemolytic Anaemia |
5.4% |
Blood Pressure Diastolic Increased |
2.7% |
Drug Interaction |
2.7% |
Dyspnoea |
2.7% |
Hypertension |
2.7% |
Hyponatraemia |
2.7% |
Multi-organ Failure |
2.7% |
Osteoporosis |
2.7% |
Premature Baby |
2.7% |
Spinal Epidural Haematoma |
2.7% |
Sudden Death |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
26.6% |
Drug Use For Unknown Indication |
14.9% |
Prophylaxis |
9.3% |
Hypertension |
6.8% |
Thrombosis Prophylaxis |
6.4% |
Pain |
6.0% |
Rheumatoid Arthritis |
5.6% |
Multiple Myeloma |
3.2% |
Nausea |
3.1% |
Glioblastoma |
2.6% |
Diarrhoea |
2.0% |
Breast Cancer |
1.7% |
Hypothyroidism |
1.7% |
Non-small Cell Lung Cancer |
1.7% |
Anticoagulant Therapy |
1.5% |
Myocardial Ischaemia |
1.5% |
Atrial Fibrillation |
1.4% |
Endocarditis |
1.4% |
Osteoporosis |
1.4% |
Stomatitis |
1.3% |
|
Sepsis |
11.9% |
Vomiting |
9.8% |
Thrombosis |
9.1% |
Renal Failure Acute |
8.4% |
Pyrexia |
6.3% |
General Physical Health Deterioration |
5.6% |
Thrombocytopenia |
4.9% |
Neutropenia |
4.2% |
Pneumonia |
4.2% |
Pulmonary Embolism |
4.2% |
Deep Vein Thrombosis |
3.5% |
Grand Mal Convulsion |
3.5% |
Panic Attack |
3.5% |
Renal Failure |
3.5% |
Tachycardia |
3.5% |
Agranulocytosis |
2.8% |
Endocarditis |
2.8% |
Femoral Artery Occlusion |
2.8% |
Hyperkalaemia |
2.8% |
Intermittent Claudication |
2.8% |
|
Interacting |
Deep Vein Thrombosis |
66.7% |
Neuralgia |
33.3% |
|
|